AI Real-Time Liver Tumor Detection and Recognition: iGood Liver AI Wins National Innovation Award!
Another glory of Taiwan! The "iGood Liver AI" software for automatic detection and identification of liver tumors using ultrasound images, jointly developed by the Good Liver Foundation, National Taiwan University Hospital, and YUAN High-Tech Development Co., Ltd. won the 21st place today ( 26th ). The National Innovation Award for Clinical Innovation! This is the first AI device for real-time ultrasound imaging in the country that was completed entirely with donations from the public. EBM Technologies Inc. and wednesday Creative Group jointly assisted in the promotion of the product.
Charity helps develop iGood Liver AI to help people with liver problems
The National Innovation Award is one of the highest awards for innovative technologies in Taiwan's biomedical and health fields. It combines innovative technologies with domestic and international industrial ecosystems to implement innovative commercialization and its application value.
The development of this device was led by Dr. Xiaojing Nian, the CEO of the Good Liver Foundation and an attending physician at the Department of Family Medicine at NTUH. Dr. Nian hoped to bring the first authority in Taiwan on diagnosing liver tumors using ultrasound, an honorary professor at the NTU Medical School, and a member of the Good Liver Foundation. Professor Xu Jinchuan, Chairman of the Association, has decades of valuable experience in ultrasound interpretation of liver tumors. This allows medical staff to help patients with abdominal ultrasound examinations, just like having a professor with rich experience in liver tumor diagnosis by their side, to assist in the immediate diagnosis of liver tumors. The good or evil nature of.
Training AI software to automatically detect and identify liver tumor images
Dr. Xiaojing Nian, CEO of the Good Liver Foundation, said that this research and development collected 6,001 liver tumor ultrasound images of 1,576 patients at National Taiwan University Hospital between 2002 and 2020, and used computerized tomography ( CT ) or magnetic resonance imaging ( MRI ) to analyze the liver tumors. The diagnosis of liver tumor is confirmed by imaging or pathological results. Then, the image is marked by each tumor site by a certified ultrasound specialist. Furthermore, at the same time as the ultrasound examination, the liver tumor benign or malignant judgment results are provided in real time, and the image is benign or malignant identification is performed. The accuracy is as high as 90%, which is comparable to the diagnosis of CT and MRI.
Don’t be alarmed about liver tumors. Doing abdominal ultrasound is like having an authoritative professor guiding you
CEO Xiaojing Nian said that the liver is too large to be examined from all angles, so it requires professional techniques and various angles to avoid interference from the ribs and gastrointestinal gas. In addition, liver ultrasound examination is not like ultrasound examination of other small organs, where only one or a few images are required. The entire organ can be seen clearly without fixed reference points (such as trachea, muscle groups or fat layers). Therefore, the liver ultrasound examination process is highly dependent on the operator's experience and skills, making it difficult to detect liver tumors early. iGood Liver AI can assist medical staff in performing abdominal ultrasound examinations. By simply connecting the ultrasound instrument and turning on the machine, the location of liver tumors and identification of benign and malignant tumors can be immediately detected on the screen. Professor Xu Jinchuan's guidance makes the patient's diagnosis and treatment more accurate and complete.
AI helps liver cancer screening and reduces patient anxiety
The diagnosis of liver cancer is quite special. It is one of the few cancers that can be diagnosed without pathological sections. Ultrasound is the main tool for early diagnosis of liver cancer because it is fast, convenient and has no radiation. When ultrasound finds liver tumors, other Advanced imaging ( such as CT or MRI ) examinations. Therefore, developing liver tumor AI to assist in interpreting ultrasound images and optimizing ultrasound accuracy to be comparable to CT or MRI will help improve the diagnosis of liver tumors and liver cancer.
Chief Executive Officer Xiaojing Nian pointed out that when patients are told that they have a liver tumor after undergoing an abdominal ultrasound examination, they are usually psychologically uneasy. If a patient is diagnosed with a benign or malignant tumor, they will face completely different follow-up examinations and even treatment plans. If iGood Liver AI, which is comparable to CT and MRI in accuracy, can be used to assist doctors in diagnosing benign or malignant liver tumors during a quick and convenient abdominal ultrasound examination, it will alleviate patients’ fear of cancer and reduce the risk of being diagnosed with cancer. The anxiety of waiting for further advanced imaging examinations can be reduced, and the arrangement and expenditure of advanced imaging medical examinations can be reduced.
iGood Liver AI obtains patents in multiple countries
This intelligent liver tumor analysis device has currently obtained patent certificates in many countries, including Taiwan, China, Japan, the European Union, etc. We hope that in the near future, the AI device can be actually used in clinical practice.
